Nestle India Share Price Falls After FSSAI Action On Baby Food Products
Join Us
Follow Us
FSSAI has initiated three adjudication cases against Nestle India over infant nutrition products, putting regulatory compliance under focus.
✨ Key Takeaways
Nestle India shares came under pressure on Friday, 18S eptemebr 2026 after the Food Safety and Standards Authority of India (FSSAI) initiated legal action against the company over certain infant nutrition products. The stock declined nearly 2 per cent during the trading session as investors reacted to the regulatory development.
The issue relates to Nestle India’s baby food portfolio, where the regulator has raised concerns over product claims and a laboratory finding related to nutritional composition. FSSAI said it has filed three separate adjudication cases against the company.
Looking for High-Growth Micro Cap Opportunities?
Explore DSIJ’s Micro Marvel - a research-driven service focused on fundamentally strong microcap stocks with the potential to create long-term wealth through high-growth opportunities.
Download Service BrochureWhat Triggered FSSAI’s Action?
According to the regulator, it examined Nestle India’s infant nutrition products along with promotional material available on e-commerce platforms.
The action covers NAN Excella Pro Stage 1 and Lactogen Pro 1. FSSAI flagged certain claims associated with these products, including references related to “5 HMOs” and “Whey Protein”. The regulator stated that these claims did not comply with applicable infant food regulations.
Separately, a sample of a follow-up formula manufactured by Nestle India was found to be below the prescribed biotin requirement during laboratory testing. The sample was subsequently sent for re-analysis, where the referral laboratory also found it non-conforming with the specified biotin standards.
Also Read - Big Pharma Trigger: Dr Reddy’s New Global Partnership Sparks Investor Buzz
Regulatory Action Brings Infant Nutrition Business Into Focus
The development has drawn attention because infant nutrition is an important category for Nestle India. The company has a strong presence across multiple consumer segments, including milk products, nutrition, prepared foods, beverages and chocolates. The latest regulatory action does not indicate a product recall or commercial impact at this stage.
Nestle India shares declined after the announcement, reflecting investor concerns around regulatory scrutiny and potential reputational impact. The stock fell around 2 per cent during the session, however, the stock recovered close to the end of the trading session to close at Rs 1,364,90 (-0.42 per cent).
Disclaimer: The article is for informational purposes only and not investment advice.